Drugs / nCAR19-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02644655 | Sep 2015 → Mar 2017 | B-cell neoplasm | Second Military Medical University | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nCAR19-T | “New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T (nCAR19-T) Cells” NCT02644655 ↗ |
| Known as | nCAR19-T Cells | “New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T (nCAR19-T) Cells” NCT02644655 ↗ |
| Modality | Cell therapy | “chimeric Antigen Receptor T (nCAR19-T) Cells” NCT02644655 ↗ |
| Route | Other | “nCAR19-T transfusion” NCT02644655 ↗ |
| Target | CD19 | “Chimeric Antigen Receptor Targeting to CD19” NCT02644655 ↗ |